Tashkent Hosts Pharma Uzbekistan Congress as Central Asia Expands Pharmaceutical Manufacturing Ambitions

Pharma leaders, investors and technology providers meet in Tashkent to explore Central Asia’s next wave of pharmaceutical growth.


"Promotional banner for the 5th Anniversary International Congress Pharma Uzbekistan & Central Asia. The event on pharmaceutical industry growth, construction and modernisation of plants will take place on 23 September 2026 in Tashkent, Uzbekistan. Featuring the iconic Hazrat Imam Complex in the background.

The 5th Anniversary International Congress “Pharma Uzbekistan and Central Asia: Construction and Modernisation of Pharmaceutical Plants” will take place on September 23, 2026, in Tashkent, bringing together pharmaceutical executives, investors, project developers, and technology providers to discuss the next phase of manufacturing growth in the region.

Hosted at Tashkent Pharma Park, an innovative scientific and industrial pharmaceutical cluster, the event will focus on investment opportunities, pharmaceutical infrastructure development, and the modernization of production facilities across Uzbekistan and Central Asia.

Uzbekistan’s Pharmaceutical Sector Enters a New Development Phase

Uzbekistan has been positioning its pharmaceutical industry as a strategic growth sector. It is supported by the development of industrial clusters, efforts to attract investment, and the adoption of international manufacturing standards.

The congress will examine the role of pharmaceutical clusters, government regulation, and Good Manufacturing Practice (GMP) standards in strengthening regional production capacity.

Key discussions will include:

  • Development of pharmaceutical manufacturing hubs in Central Asia
  • Investment attraction strategies for pharmaceutical projects
  • Construction and modernization of production facilities
  • Implementation of GMP standards and international quality requirements
  • Opportunities for technology providers and international investors

Investment Projects and Industrial Expansion

A central part of the congress will be the review of current and prospective pharmaceutical investment projects, presented by project initiators.

The sessions will highlight ongoing and planned developments aimed at expanding manufacturing capabilities, improving production infrastructure, and supporting the growth of the pharmaceutical sector in Uzbekistan.

The organizers are also providing access to a full list of regional investment projects for interested stakeholders.

Key Participants

The congress is expected to bring together more than 150 senior executives and industry representatives, including:

  • Leaders from Central Asia’s pharmaceutical companies
  • Investors and project initiators
  • Equipment and technology suppliers
  • International pharmaceutical industry representatives

The event is designed to facilitate direct dialogue between manufacturers, investors, and solution providers involved in pharmaceutical infrastructure development.

Strategic Agenda

The programme will include a strategic opening session titled “Pharma Uzbekistan: A New Growth Hub for Central Asia’s Pharmaceutical Industry.”

Discussions will focus on:

  • The future development of Uzbekistan’s pharmaceutical ecosystem
  • Regulatory frameworks shaping the sector
  • The role of pharmaceutical clusters in industrial growth
  • Investment opportunities across Central Asia
  • Modernization strategies for pharmaceutical plants

About the Congress

The 5th Anniversary International Congress “Pharma Uzbekistan and Central Asia: Construction and Modernisation of Pharmaceutical Plants” is an industry platform connecting pharmaceutical manufacturers, investors, project initiators, and technology providers.

The event will take place on September 23, 2026, at Tashkent Pharma Park in Tashkent, Uzbekistan.

For more information, visit the official event website.